Cargando…

Effects of stereotactic body radiotherapy for clinical outcomes of patients with liver metastasis and hepatocellular carcinoma: A retrospective study

This retrospective clinical study described the treatment efficacy and safety of stereotactic body radiotherapy (SBRT) for patients of hepatocellular carcinoma (HCC) and liver metastasis tumors. The therapeutic effect and prognosis of patients with liver cancer treated with stereotactic body radiati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Canyu, Yi, Qiong, Zhou, Xuerong, Han, Xu, Jiang, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265345/ https://www.ncbi.nlm.nih.gov/pubmed/37323818 http://dx.doi.org/10.3892/ol.2023.13891

Ejemplares similares

Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma
por: Lee, Eonju, et al.
Publicado: (2015)

Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
por: Park, Jongmoo, et al.
Publicado: (2019)

Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Brief Overview
por: Matsuo, Yukinori
Publicado: (2023)

Stereotactic ablative body radiotherapy for spinal metastasis from hepatocellular carcinoma: its oncologic outcomes and risk of vertebral compression fracture
por: Yoo, Gyu Sang, et al.
Publicado: (2017)

Efficacy of Stereotactic Body Radiotherapy in Patients With Hepatocellular Carcinoma Not Suitable for Transarterial Chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study)
por: Brunner, Thomas B., et al.
Publicado: (2021)

Neuroendocrine Carcinoma of Uterine Cervix: Stereotactic Radiotherapy for Brain Metastasis and Stereotactic Body Radiotherapy for Renal and Pancreatic Metastases
por: Mori, Yoshimasa, et al.
Publicado: (2020)

Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma
por: Yamashita, Hideomi, et al.
Publicado: (2015)

Stereotactic body radiotherapy for solitary spine metastasis
por: Lee, Sunyoung, et al.
Publicado: (2013)

Comparison of clinical outcome between stereotactic body radiotherapy and radiofrequency ablation for unresectable hepatocellular carcinoma
por: Ji, Ren, et al.
Publicado: (2022)

Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy
por: Hasan, Shaakir, et al.
Publicado: (2017)

Stereotactic Body Radiotherapy: Does It Have a Role in Management of Hepatocellular Carcinoma?
por: Choi, Seo Hee, et al.
Publicado: (2018)

Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study
por: Su, Ting-Shi, et al.
Publicado: (2021)

Comparison of Combination Stereotactic Body Radiotherapy Plus High-Intensity Focused Ultrasound Ablation Versus Stereotactic Body Radiotherapy Alone for Massive Hepatocellular Carcinoma
por: Wang, Lei, et al.
Publicado: (2018)

Lenvatinib with or without stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective study
por: Ji, Xiaoquan, et al.
Publicado: (2023)

Metastasis-directed stereotactic body radiotherapy for oligometastatic renal cell carcinoma: extent of tumor burden eradicated by radiotherapy
por: Liu, Yang, et al.
Publicado: (2021)

Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma
por: Abe, Takanori, et al.
Publicado: (2015)

Combining stereotactic body radiotherapy with camrelizumab for unresectable hepatocellular carcinoma: a single-arm trial
por: Li, Jian-Xu, et al.
Publicado: (2022)

Efficacy of Stereotactic Body Radiotherapy for Recurrent or Residual Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization
por: Yao, Erhua, et al.
Publicado: (2018)

Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma
por: Kim, Jun Won, et al.
Publicado: (2016)

Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis
por: Pan, Yang-Xun, et al.
Publicado: (2020)

Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters
por: Jung, Jinhong, et al.
Publicado: (2013)

Orthotopic Liver Transplantation After Stereotactic Body Radiotherapy for Pediatric Hepatocellular Carcinoma with Central Biliary Obstruction and Nodal Involvement
por: Chen, Emily, et al.
Publicado: (2018)

Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular Carcinoma
por: Hsiang, Chih-Weim, et al.
Publicado: (2021)

Commentary: Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis
por: Li, Zhaonan, et al.
Publicado: (2021)

Simultaneous Multiple Liver Metastasis Treated with Pencil Beam Proton Stereotactic Body Radiotherapy (SBRT)
por: Taunk, Neil K., et al.
Publicado: (2021)

Stereotactic Body Radiotherapy (SBRT) for liver metastasis – clinical outcomes from the international multi-institutional RSSearch® Patient Registry
por: Mahadevan, Anand, et al.
Publicado: (2018)

Feasibility and Efficacy of Stereotactic Ablative Radiotherapy for Barcelona Clinic Liver Cancer-C Stage Hepatocellular Carcinoma
por: Bae, Sun Hyun, et al.
Publicado: (2013)

Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer
por: Kwon, Jung Hyun, et al.
Publicado: (2010)

Stereotactic Body Radiation Therapy for Recurrent, Isolated Hepatocellular Carcinoma Lymph Node Metastasis With or Without Prior Liver Transplantation
por: Walburn, Tyler, et al.
Publicado: (2020)

Defining Radiation-Induced Hepatic Toxicity in Hepatocellular Carcinoma Patients Treated with Stereotactic Body Radiotherapy
por: Song, Jin Ho, et al.
Publicado: (2017)

Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis
por: Shui, Yongjie, et al.
Publicado: (2018)

Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma
por: Gkika, Eleni, et al.
Publicado: (2017)

Hepatocellular Carcinoma in the COVID‐19 Era: Primetime for Stereotactic Body Radiotherapy and a Lesson for the Future?
por: Scorsetti, Marta, et al.
Publicado: (2020)

Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review
por: Wang, Haiyin, et al.
Publicado: (2020)

Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Cohort Study
por: Fu, Yizhen, et al.
Publicado: (2020)

Outcomes After Stereotactic Body Radiation Therapy as a Bridging Modality to Liver Transplantation for Hepatocellular Carcinoma
por: Garg, Rashi, et al.
Publicado: (2020)

Stereotactic Ablative Radiotherapy Fractionation for Hepatocellular Carcinoma in the United States
por: Sheth, Niki, et al.
Publicado: (2020)

Radiofrequency ablation versus stereotactic body radiotherapy for small hepatocellular carcinoma: a Markov model‐based analysis
por: Seo, Young‐Seok, et al.
Publicado: (2016)

Developments in Stereotactic Body Radiotherapy
por: Haridass, Anoop
Publicado: (2018)

Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Propensity Score Matching Study
por: Pan, Yang-Xun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5h12ccpq0c1epn782cscumnv29